HNF1A and MODY: A correct molecular diagnosis is of utmost importance, since subjects with HNF1A-MODY are usually very sensitive to oral treatment with sulphonylurea derivatives (SU) such as gliclazide, which can provide excellent diabetes control for decades (7).